Vascepa is a prescription medication used to treat high levels of triglycerides in the blood. It contains the active ingredient icosapent ethyl, which is a type of omega-3 fatty acid. According to Drug Patent Watch , Vascepa has been approved by the FDA for use in combination with a statin to reduce the risk of cardiovascular events in adults with elevated triglyceride levels.
The article in the American Journal of Managed Care  explains that Vascepa has been shown to be effective in reducing the risk of cardiovascular events, regardless of the type of statin a patient is taking. The study found that patients taking Vascepa in combination with either a moderate- or high-intensity statin had a similar reduction in cardiovascular events compared to those taking a placebo in addition to a statin.
However, it is important to note that the combination of Vascepa and certain statins may increase the risk of certain side effects. According to Medical News Today , taking Vascepa with simvastatin or lovastatin may increase the risk of muscle pain and weakness. Patients taking these statins should be closely monitored for these side effects if they are also taking Vascepa.
In conclusion, while Vascepa has been shown to be effective in reducing the risk of cardiovascular events in combination with a statin, it is important to consult with a healthcare provider to determine if it is safe to take with a specific type of statin. Patients taking Vascepa with simvastatin or lovastatin should be closely monitored for potential side effects.